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Abstract 20 
For aquaculture of marine species to continue to expand, dietary fish oil (FO) must be replaced 21 
with more sustainable vegetable oil (VO) alternatives. Most VO are rich in n-6 polyunsaturated 22 
fatty acids (PUFA) and few are rich in n-3 PUFA but Camelina oil (CO) is unique in that, besides 23 
high 18:3n-3 and n-3/n-6 PUFA ratio, it also contains substantial long-chain monoenes, 24 
commonly found in FO. Cod (initial weight ~1.4 g) were fed for 12 weeks diets in which FO was 25 
replaced with CO. Growth performance, feed efficiency and biometric indices were not affected 26 
but lipid levels in liver and intestine tended to increase and those of flesh, decrease, with 27 
increasing dietary CO although only significantly for intestine. Reflecting diet, tissue n-3 long-28 
chain PUFA levels decreased whereas 18:3n-3 and 18:2n-6 increased with inclusion of dietary 29 
CO. Dietary replacement of FO by CO did not induce major metabolic changes in intestine, but 30 
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affected genes with potential to alter cellular proliferation and death as well as change structural 31 
properties of intestinal muscle. Although the biological effects of these changes are unclear, 32 
given the important role of intestine in nutrient absorption and health, further attention should be 33 
given to this organ in future.  34 
 35 
Keywords: Alternative diets; Camelina sativa; fish oil replacement; Gadus morhua; intestine; 36 
microarrays  37 
 38 
1. Introduction 39 
Sustainable development of aquaculture of carnivorous marine finfish species requires feed 40 
formulations to be based more on terrestrial plant products, plant meals and vegetable oils (VO), 41 
rather than the traditional marine resources, fishmeal and fish oil (FO) (Naylor et al., 2009; 42 
Hardy, 2010). Recent research has demonstrated that marine fish can be grown on feeds 43 
containing high levels of replacement (up to 70%) of FO with VO without compromising growth 44 
performance (Turchini et al., 2010). However, VO lack long-chain polyunsaturated fatty acids 45 
(≥C20; LC-PUFA) and most are rich in linoleic acid (18:2n-6; LOA), and their inclusion in feeds 46 
reduces the n-3/n-6 PUFA ratio of the fish flesh potentially compromising its nutritional quality 47 
to human consumers (Turchini et al., 2010). In contrast there are few oils rich in n-3 PUFA and 48 
they are only produced in relatively small volumes (Gunstone, 2010).  49 
      A potentially new source of n-3 PUFA is the (re)emerging Brassicaceae species Camelina 50 
sativa (commonly known as gold-of-pleasure, or false flax). Camelina used to be a major 51 
European oilseed crop prior to the early 20th century, and has recently been re-established as a 52 
potential bioenergy crop. This is on account of Camelina’s modest input requirements and also its 53 
ability to thrive in semi-arid conditions (Tocher et al., 2010) and, in the USA, it is being actively 54 
grown as a biofuels crop (Murphy, 2011). In addition to these desirable agronomic traits, 55 
Camelina also accumulates high levels of α-linolenic acid (18:3n-3; ALA). Thus, Camelina oil 56 
(CO) can contain up to 45 % ALA with an ALA/LOA ratio generally around 2.5. However, CO 57 
also has a high antioxidant content with approximately 800 mg total tocopherol per kg, 58 
predominantly the γ-isomer and, as a result, the crude oil exhibits strong oxidative stability 59 
despite the high ALA content (Tocher et al., 2010). Camelina oil is relatively low in saturated 60 
fatty acids and, almost uniquely among VO, it contains high levels of long-chain C20 and C22 61 
monoenes (20:1 and 22:1) that are regarded as good energy sources in fish (Tocher, 2003), giving 62 
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CO a potential nutritional advantage over other ALA-rich oils such as linseed and perilla (Tocher 63 
et al., 2010). Furthermore, CO has already been shown to be suitable for inclusion in feeds for 64 
Atlantic salmon and appears to be low in anti-nutritional factors that could be detrimental to fish 65 
growth (Petropoulos et al., 2009). 66 
       Until depletion of the commercial stocks in the 1990’s, Atlantic cod (Gadus morhua L.) was 67 
the most valued food fish obtained from the North Atlantic (Kurlansky, 1998). Significant 68 
progress has been made in the culture of cod and the life cycle was closed some years ago, 69 
allowing production independent of wild fisheries (Brown et al., 2003). The large and highly 70 
developed market for cod, high market price and quotas set to preserve wild stocks, have 71 
stimulated considerable interest in cod culture over the years (Morais et al., 2001; Hemre et al., 72 
2004; Hansen et al., 2011; Kortner et al., 2011).  However, the establishment of large-scale, 73 
sustainable cod culture will require solutions to several nutritional issues including broodstock 74 
and larval nutrition and replacement of dietary FO (Lall and Nanton, 2002; Salze et al., 2005). 75 
Recently the genome of Atlantic cod was released, providing an important resource for further 76 
studies and development of cod as an aquaculture species (Star et al., 2011). 77 
    In addition to traditional measures of the effects of dietary formulations on fish performance 78 
(growth and feed efficiency), tissue composition and nutritional quality, recent advances in 79 
functional genomics, essentially the study of gene expression, has opened up new possibilities for 80 
understanding the basic mechanisms involved in the adaptation to new diets or feeds (Leaver et 81 
al., 2008a). Determining patterns of gene expression through study of tissue transcriptomes 82 
(mRNA expression) or proteomes (protein expression) can provide large amounts of information 83 
on individual molecular responses that, with detailed bioinformatic analyses, can provide great 84 
insights into the biochemical and physiological responses underpinning nutritional adaptations 85 
(Panserat et al., 2009; Taggart et al., 2008). In recent years, we have specifically determined the 86 
effects of replacement of FO with VO on tissue gene expression in Atlantic salmon using both 87 
quantitative real-time PCR (candidate genes) and transcriptomic/microarray (global gene 88 
expression) approaches (Leaver et al., 2008b; Torstensen and Tocher, 2010; Morais et al., 89 
2011a,b).   90 
    Our overall objective is to determine the utility of CO as a replacement for dietary FO in feeds 91 
for Atlantic cod and, to this aim, cod were fed CO in a nutritional trial with a regression design 92 
and the effects on growth performance, feed efficiency, basic biometry and tissue lipid and fatty 93 
acid composition determined. However, the primary focus of the present study was to determine 94 
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the effects of dietary CO on gene expression in cod in order to elucidate metabolic pathways of 95 
adaptation and provide an underpinning fundamental science base for similar nutritional studies. 96 
Therefore, transcriptome analysis of intestinal tissue was performed using a recently developed 97 
Atlantic cod 16k cDNA microarray (Edvardsen et al., 2011).  98 
 99 
2. Materials and methods 100 
2.1. Diets and animals 101 
Four diets containing approximately 55 % crude protein and 15 % crude lipid were formulated to 102 
satisfy the nutritional requirements of marine fish (National Research Council, 2011). The control 103 
diet (C0) was formulated with 100% FO (capelin oil) and three other diets contained an 104 
increasing proportion of crude cold-pressed Camelina sativa oil (CO) replacing 33 % (C33), 66 105 
% (C66) and 100 % (C100) of the added fish oil (Table 1). The dry ingredients were combined 106 
and mixed for 5 min using a Hobart commercial mixer (Model 200A, Hobart, Glasgow, UK), and 107 
the oils, including antioxidant, then added and mixed for 5 min before adding water (10% w/w) 108 
and mixing for a further 5 min. Pellets of 1 mm diameter were formed by extrusion through an 109 
appropriate die using a California pellet mill (model CL3, California Pellet Mill Inc., San 110 
Francisco, CA). After pelleting the feeds were dried overnight in a heated cabinet at 25oC. The 111 
fatty acid compositions of the diets are shown in Table 2.  112 
Four hundred and twenty juveniles of Atlantic cod (Gadus morhua L.), obtained from Marine 113 
Farms Ltd, Machrihanish, UK, of initial mean weight 1.4 ± 0.1 g were randomly distributed 114 
among 12 circular fibreglass tanks of 0.4 m3 with 35 fish/tank and supplied with UV treated, 115 
filtered flow-through seawater at a rate of 1 L/min at the Marine Environmental Research 116 
Laboratory, Machrihanish, Scotland. Triplicate tanks of fish were fed one of the four feeds for 12 117 
weeks between February and May when ambient water temperature was 9.0 ± 1.2 oC (range, 7 – 118 
11). Fish were fed a fixed ration of tank biomass ranging from 5.6 – 2.6 % as the experiment 119 
progressed with fish in each tank bulk weighed every 14 days and ration adjusted accordingly. At 120 
the end of the trial, 6 fish per tank (18 fish per dietary treatment) were anaesthetized with 121 
metacaine sulphonate (MS222; 50 mg/L) and killed by a blow to the head. Samples of liver and 122 
intestine (midgut) for analysis of gene expression were frozen in liquid nitrogen and subsequently 123 
stored at – 80 oC prior to RNA extraction. Flesh (muscle), liver and intestine for lipid analyses 124 
were also frozen in liquid nitrogen and stored at -20 oC prior to analysis. Fish were not starved 125 
prior to sampling and so any gut contents were gently extruded prior to freezing. 126 
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2.2. Proximate composition 127 
Diets were ground prior to determination of proximate composition according to standard 128 
procedures (AOAC, 2000). Moisture contents were obtained after drying in an oven at 110 oC for 129 
24 h and ash content determined after incineration at 600 oC for 16 h. Crude protein content was 130 
measured by determining nitrogen content (N × 6.25) using automated Kjeldahl analysis (Tecator 131 
Kjeltec Auto 1030 analyzer, Foss, Warrington, U.K), and crude lipid content determined after 132 
acid hydrolysis followed by Soxhlet lipid extraction (Tecator Soxtec system 2050 Auto 133 
Extraction apparatus, Foss, Warrington, U.K).  134 
2.3. Lipid content and fatty acid analysis  135 
Samples of liver, intestine and skinned and deboned flesh (white muscle) from three fish per tank 136 
(9 per treatment) were utilized for lipid analysis, with samples from the three fish per tank 137 
prepared as pooled tissue homogenates and so there were three replicate pools of three fish per 138 
treatment (n = 3).  Total lipid was extracted according to the method of Folch et al. (1957). 139 
Approximately 1 g samples of pooled tissues  were homogenized in 20 ml of ice-cold 140 
chloroform/methanol (2:1, by vol) using an Ultra-Turrax tissue disrupter (Fisher Scientific, 141 
Loughborough, U.K.). The non-lipid and lipid layers were separated by addition of 5 ml of 0.88 142 
% (w/v) KCl and allowed to separate on ice for 1 h. The upper non-lipid layer was aspirated and 143 
the lower lipid layer dried under oxygen-free nitrogen. The lipid content was determined 144 
gravimetrically after drying overnight in a vacuum desiccator. Fatty acid methyl esters (FAME) 145 
were prepared from total lipid by acid-catalyzed transesterification at 50 oC for 16 h according to 146 
the method of Christie (1993). Extraction and purification of FAME was carried out as described 147 
by Tocher and Harvie (1988). The FAME were separated and quantified by gas-liquid 148 
chromatography (Carlo Erba Vega 8160, ThermoFisher Scientific, Hemel Hempsted, UK) using 149 
a 30m x 0.32 mm i.d. capillary column (CP Wax 52CB, Chrompak, London, U.K.) and on-150 
column injection at 50 oC. Hydrogen was used as carrier gas and temperature programming was 151 
from 50 oC to 150 oC at 40 oC min-1 and then to 230 oC at 2.0 oC min-1. Individual methyl esters 152 
were identified by comparison with known standards and by reference to published data 153 
(Ackman, 1980; Tocher and Harvie, 1988). Data were collected and processed using Chromcard 154 
for Windows (version 1.19). 155 
2.4. RNA extraction  156 
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Liver and intestinal tissue (0.2 g) from six individuals per experimental group (2 per tank) 157 
were homogenized in 2mL of TRI Reagent (Ambion, Applied Biosystems, Warrington, U.K.) 158 
using an Ultra-Turrax tissue disrupter (Fisher Scientific, Loughborough, U.K.). The individuals 159 
were selected from the group of randomly sampled fish to represent the global average weight of 160 
fish in the experiment. Total RNA was isolated following manufacturer’s instructions, and RNA 161 
quality (integrity and purity) and quantity was assessed by gel electrophoresis and 162 
spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.).  163 
2.5. Transcriptome analysis 164 
A 16 k cDNA microarray from Atlantic cod was used in this experiment. Details of the 165 
microarray construction are given in Edvardsen et al. (2011). Only intestinal samples from the 166 
control (C0) and one of the CO dietary treatments (C66) were hybridized. The C66 diet was 167 
chosen rather than C100, as this would be the more likely commercial formulation. The low yield 168 
and quality of RNA obtained from liver, possibly due to high co-precipitation with glycogen, 169 
precluded the use of liver samples for the microarray experiment. Total RNA was purified using 170 
the Invitrogen iPrep Trizol® Plus RNA Kit on the iPrepT Purification Instrument following the 171 
manufacturer’s recommendations. Samples were randomly labelled in a single batch and 172 
hybridized in 2 batches of 6 slides each, containing 3 samples from each treatment in each batch. 173 
Briefly, 10 µg total RNA was used for cDNA synthesis and labelling using Fair Play® 174 
Microarray Labeling Kit (Stratagene, USA) according to manufacturer's instructions. Samples 175 
were labelled with Cy5 and a common reference standard (obtained by pooling 40% intestinal 176 
RNA from all samples in the microarray experiment plus 60% RNA from a mixture of different 177 
tissues) was labelled with Cy3. Labelling efficiency and quantity of labelled cDNA were 178 
determined using the NanoDrop spectrophotometer. Slides were pre-hybridized in 20× SSC 179 
(Calbiochem, USA), 10% SDS (Sigma-Aldrich Chemie, Steinheim, Germany) and 1% BSA 180 
(Sigma-Aldrich Chemie) for 45 min at 65 °C followed by washing twice in water and once in 181 
isopropanol, and then drying by centrifugation. Sample and reference labelled cDNA were 182 
pooled and diluted in Tris buffer pH 8.0. After sample denaturation (100 °C, 2 min), 183 
hybridization was performed at 60 °C overnight with rotation using Agilent 2× hybridization 184 
buffer (250 µL) in Agilent hybridization chambers. The slides were put in 2× SSC/0.1% SDS at 185 
65 °C to remove gasket slide and then washed for 5 min in 1×SSC at 65 °C, for 5 min in 0.2× 186 
SSC at RT, for 45 s in 0.05× SSC at RT, and centrifuged dry. Slides were immediately scanned 187 
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using an Agilent scanner (G2505 B Microarray Scanner, Agilent Technologies, Santa Clara, 188 
USA) at a resolution of 10 µm with default settings. 189 
The scanned microarray images were analyzed using the GenePix Pro 6.0 software package 190 
and exported as image quantitation files (gpr- and jpg-files). The data files were quality 191 
controlled using R (R Development Core Team, 2005, http://www.r-project.org), and analyzed 192 
using J-Express Pro v.2.7 (Dysvik and Jonassen, 2001, http://www.molmine.com). Control 193 
probes, empty spots and probes marked as bad quality were removed from the analysis. Genes 194 
with more than 30% missing values were removed from the analysis and the remaining missing 195 
values were estimated using LSimpute Adaptive (Bø et al., 2004). Each array was normalized by 196 
Lowess (Cleveland and Devlin, 1988). Log 2 transformed ratios of foreground signals were used 197 
in the final gene expression matrix. MIAME-compliant (Brazma et al., 2001) descriptions of the 198 
microarray study and results are available in the EBI ArrayExpress database 199 
(http://www.ebi.ac.uk/arrayexpress) under accession number E-TABM-1178. 200 
Statistical analysis of the microarray hybridization data was performed in GeneSpring GX 201 
version 11 (Agilent Technologies, Wokingham, Berkshire, U.K.) using a Welch (unpaired 202 
unequal variance) t-test, at 0.05 significance and 1.2 fold change cut-off level. No multiple test 203 
correction was employed as previous analyses, confirmed by RT-qPCR, indicate that such 204 
corrections are over-conservative for this type of nutritional data (Leaver et al., 2008b; Morais et 205 
al., 2011a). Gene Ontology (GO) enrichment analysis was performed using the same software, at 206 
p < 0.05. 207 
2.6. Reverse transcription real-time quantitative PCR (RT-qPCR) 208 
Expression of candidate genes of interest (fatty acyl elongase, elovl5, and desaturase, Δ6fad) 209 
in intestine and liver from fish fed all four treatments, as well as genes for microarray validation 210 
in intestinal samples of fish fed C0 and C66, was determined by reverse transcription quantitative 211 
real time PCR (RT-qPCR). Details on the target qPCR primer sequences and on the reference 212 
sequences used to design them are given in Table 3. Primers were designed using Primer3 213 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi; Rozen and Skaletsky, 2000). Results 214 
were normalized by amplification of three reference genes, β-actin (bact), ubiquitin (ubq) and 215 
glyceraldehyde 3-phosphate dehydrogenase (gapdh), which in our experimental conditions 216 
presented M values, generated by the gene stability analysis software package geNorm 217 
(Vandesompele et al., 2002), of 0.292, 0.268 and 0.326, respectively. 218 
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For RT-qPCR, 1 µg of total RNA per sample was reverse transcribed into cDNA using the 219 
VersoTM cDNA kit (ABgene, Surrey, U.K.), following manufacturer’s instructions, using a 220 
mixture of random hexamers (400ng/µL) and anchored oligo-dT (500ng/µL) at 3:1 (v/v). 221 
Negative controls (containing no enzyme) were performed to check for genomic DNA 222 
contamination. A similar amount of cDNA was pooled from all samples and the remaining 223 
cDNA was then diluted 20-fold with water. RT-qPCR analysis used relative quantification with 224 
the amplification efficiency of the primer pairs being assessed by serial dilutions of the cDNA 225 
pool. qPCR amplifications were carried out in duplicate (Quantica, Techne, Cambridge, U.K.) in 226 
a final volume of 20 µL containing either 5 µL or 2 µL diluted (1/20) cDNA, 0.5 µM of each 227 
primer and 10 µL AbsoluteTM QPCR SYBR® Green mix (ABgene). Amplifications were 228 
carried out with a systematic negative control (NTC-non template control). The qPCR profiles 229 
contained an initial activation step at 95 °C for 15 min, followed by 30 to 35 cycles: 15 s at 95 230 
°C, 15 s at the specific primer pair annealing temperature (Ta; Table 3) and 15 s at 72 °C. After 231 
the amplification phase, a melt curve of 0.5 °C increments from 75 ºC to 90 °C was performed, 232 
enabling confirmation of the amplification of a single product in each reaction. RT-qPCR product 233 
sizes were checked by agarose gel electrophoresis and the identity of amplicons was confirmed 234 
by sequencing. PCR efficiency was above 90% for all primer pairs. 235 
Gene expression results assessed by RT-qPCR were analyzed by the ΔΔCt method using the 236 
relative expression software tool (REST 2008, http://www.gene-quantification.info/), employing 237 
a pair wise fixed reallocation randomization test (10,000 randomisations) with efficiency 238 
correction (Pfaffl et al., 2002), to determine the statistical significance of expression ratios 239 
between two treatments.  240 
2.7. Statistical analysis 241 
All data are presented as means ± SD (n value as stated). The effects of dietary treatment on 242 
growth performance were analyzed by one-way analysis of variance (ANOVA) followed, where 243 
appropriate, by Tukey’s post hoc test. The relationship between dietary treatment and chemical 244 
composition was analyzed by regression analysis. Percentage data and data identified as non-245 
homogeneous (Levene’s test) or non-normality (Shapiro-Wilks’s test) were subjected to arcsine 246 
transformation before analysis. ANOVA and regression analysis were performed using a SPSS 247 
Statistical Software System version 14 (SPSS inc, Chicago IL, USA). Differences were regarded 248 
as significant when P < 0.05 (Zar, 1999).  249 
  250 
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3. Results 251 
3.1. Growth and biometry 252 
The juvenile cod showed a 5-fold increase in weight over the course of the feeding experiment 253 
(Table 4). There were no significant differences between treatments for any of the growth and 254 
feeding performance parameters although there was a trend for growth performance to increase 255 
with CO inclusion up to 66% with fish fed diet C66 showing highest final weight, SGR and TGC 256 
and lowest FCR. In general, very high and variable lipid content was observed in liver, as is 257 
typical of farmed cod which normally present enlarged fatty livers (Morais et al., 2001). There 258 
were also trends for increased HSI and VSI, as well as liver lipid contents with CO inclusion but 259 
only intestinal lipid content was significantly higher in fish fed diet C66 compared to fish fed diet 260 
C0 (Table 4).  261 
3.2. Diet and cod tissue fatty acid compositions 262 
The fatty acid compositions of the feeds reflected the increasing content of CO, with decreasing 263 
proportions of total saturated fatty acids, mainly 14:0 and 16:0, and total monoenes, specifically 264 
16:1 and 22:1, although 18:0, and 18:1n-9 increased (Table 2). It was noteworthy that the level of 265 
20:1 was constant across the feeds indicating that the 20:1 content of the FO (a northern 266 
hemisphere oil) was balanced by the 20:1 content of CO. In contrast, LOA (18:2n-6) and ALA 267 
(18:3n-3) and their immediate elongation products, 20:2n-6 and 20:3n-3 respectively, increased 268 
with dietary CO inclusion whereas the LC-PUFA, including arachidonic acid (20:4n-6; ARA), 269 
eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA) all decreased.  270 
The overall effect on dietary PUFA levels was increased total n-6 PUFA, n-3 PUFA and total 271 
PUFA, but decreasing n-3/n-6 ratio (Table 2). The fatty acid compositions of the cod tissues 272 
reflected those of the feeds with liver (Table 5), intestine (Table 6) and muscle (Table 7) all 273 
characterized by generally decreasing proportions of saturated and monounsaturated fatty acids, 274 
and increasing proportions of PUFA as dietary CO inclusion increased. These effects were due to 275 
decreasing proportions of 16:0, 16:1n-7, 18:1n-7, 22:1, ARA, EPA and DHA, and increased 276 
proportions of 18:1n-9, LOA, ALA, 20:2n-6 and 20:3n-3, which together resulted in decreased 277 
tissue n-3/n-6 PUFA ratios as CO inclusion increased (Tables 5-7).  278 
3.3. Expression of fatty acyl elongase and desaturase in liver and intestine 279 
The expression of a fatty acyl elongase (elovl5) and desaturase (Δ6des) in the liver and intestine 280 
of Atlantic cod fed increasing levels of CO was assessed by RT-qPCR (Fig. 1). Changes in the 281 
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relative expression of both genes in fish fed the three diets containing CO, in relation to the C0 282 
diet, were not significantly different. In the case of elovl5, expression ratios were around 1 in 283 
both intestine and liver in fish fed all diets, denoting no change in transcript levels. In liver, in 284 
spite of a high biological variability, a trend for higher expression of Δ6des in fish fed C66, 285 
followed by C100, in comparison to fish fed C0 (2.4- and 1.8-fold up-regulated, respectively), 286 
was observed, whereas such a trend was not evident (only 1.2-fold up-regulated in C66) in the 287 
intestine.  288 
3.4. Transcriptomic analysis of intestinal tissue 289 
Statistical analysis of the microarray data returned a list of 289 features differentially 290 
expressed in the intestine between cod fed C0 and C66. Genes in this list were categorized 291 
according to their biological function, by determining the main biological processes in which 292 
they are involved in mammalian counterparts. Distribution of the EST’s, after removing non-293 
annotated genes (36%) and features representing the same gene product (Fig. 2), revealed that the 294 
most affected biological processes or categories were translation (18% of all genes), cell 295 
proliferation, differentiation and apoptosis (14%) and genes with a structural molecule activity 296 
(12%), followed by transporter activity (9%) and immune response (7%). In contrast, metabolism 297 
appeared to be less affected, with 6% of the genes involved in proteolysis, 5% involved in energy 298 
metabolism or generation of precursor metabolites and 4% in lipid metabolism. Other minor 299 
categories represented were regulation of transcription (4%), signalling (4%) and protein folding 300 
(3%). A more detailed analysis of the list was restricted to the top 100 most significant hits, 301 
which presented a broadly similar distribution of genes by biological categories, with translation 302 
(25%) and cell proliferation, differentiation and apoptosis (20%) predominating, followed by 303 
structural molecules (9%) and immune response (9%) (Table 8). 304 
Gene ontology (GO) enrichment analysis was performed on the entire significant dataset. This 305 
enabled identification of GO terms significantly enriched in the input entity list compared to the 306 
whole array dataset, providing evidence for which biological processes may be particularly 307 
altered in the experimental conditions being compared. The analysis returned 208 significant GO 308 
terms at p<0.05. However, most of the GO terms were interrelated and many of them were 309 
significantly enriched largely due to the repetition of multiple features for the same gene, either 310 
apolipoprotein A-IV (apoA-IV) or creatine kinase (CK) (Table 8). Nonetheless, some GO terms 311 
could be considered as significantly enriched by the presence of multiple genes. With respect to 312 
molecular function, the term “actin binding” was significantly enriched (adjusted p-value: 313 
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1.825E-4), containing features corresponding to myosin heavy chain, tropomyosin alpha-1 chain, 314 
actin alpha cardiac muscle 1, cofilin 1 (non-muscle), ectodermal-neural cortex (with BTB-like 315 
domain) and transgelin (Table 9). On the other hand, a few related categories of biological 316 
process, namely “multicellular organismal development” (adjusted p-value: 0.002), “anatomical 317 
structural development” (adjusted p-value: 0.003), “developmental process” (adjusted p-value: 318 
0.006), “epidermal cell differentiation” (adjusted p-value: 0.031), and “regulation of cytoskeleton 319 
organization” (adjusted p-value: 0.01), were significantly enriched due to the presence of the 320 
following genes: CK, zinc finger protein 313, P-cadherin, collagen type II alpha 1, caspase 3, 321 
myosin light polypeptide 6B, thioredoxin interacting protein, phytanoyl-CoA 2-hydroxylase, 322 
cofilin 1 (non-muscle), NAD(P) dependent steroid dehydrogenase-like, ectodermal-neural cortex 323 
(with BTB-like domain), dihydrolipoamide dehydrogenase, ribosomal protein L35, thioredoxin 324 
interacting protein, peripheral myelin protein 22, tropomyosin 1 (alpha), intraflagellar transport 325 
172 homolog, tumor susceptibility gene 101, transgelin, heat shock protein 90kDa alpha 326 
(cytosolic) class B member 4, stress-associated endoplasmic reticulum protein 2 and guanine 327 
nucleotide binding protein (G protein) (changes in expression between treatments can be found in 328 
supplementary material). 329 
3.5. RT-qPCR validation of microarray results 330 
The expression of selected genes was measured by RT-qPCR in order to validate the 331 
microarray results (Table 10). These genes were selected from within the categories that were 332 
more highly represented in the top100 most-significant list. In general, changes in expression 333 
levels were subtle, as in the microarray analysis, which explains why differences in transcript 334 
levels between fish fed diets C0 and C66 determined by RT-qPCR were not always statistically 335 
significant. However, a good match between the fold changes measured by microarray and RT-336 
qPCR results was found for most genes related to cell proliferation and apoptosis, such as tumor 337 
protein p63 regulated 1-like (tprg1l), retinoic acid receptor responder protein 3 (rarres3), 338 
translationally-controlled tumour protein homolog (tctp) and caspase 3 (casp3), even if 339 
differences assessed by RT-qPCR were only significant for rarres3 and casp3, these being 7.8- 340 
and 1.9-fold up-regulated, respectively, in the intestine of fish fed diet C66. In contrast, no 341 
agreement was found between the fold changes measured by microarray and RT-qPCR in genes 342 
related to translation, namely, elongation factor 1-alpha (elf1a), 60S ribosomal protein L13 343 
(rpl13) and eukaryotic translation initiation factor 3 subunit F (etf3f). However, good agreement 344 
was found for the gene coding for the structural protein tropomyosin alpha-1 chain (tpm), which 345 
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was 1.5-fold up-regulated in diet C66 in both the microarray and RT-qPCR analysis, although 346 
RT-qPCR did not confirm the microarray results for other structural genes, tektin-4 (tekt4) and 347 
cadherin 3 type 1 (cdh3). 348 
 349 
4. Discussion 350 
There was no detrimental effect, and even a tendency for positive effects, of dietary CO on 351 
growth of cod up to 66 % inclusion in the fishmeal-based feeds used in the present trial. As a 352 
result the microarray gene expression data compared fish fed diet C0 (control) with fish fed diet 353 
C66, which showed good adaptation to the alternative formulation. The effects on growth were 354 
similar to those previously reported for replacement of dietary FO with the most common ALA-355 
rich oil, linseed, in marine fish including gilthead sea bream (Sparus aurata), sharpsnout sea 356 
bream (Diplodus puntazzo), European sea bass (Dicentrarchus labrax) and turbot (Psetta 357 
maxima) (Tocher et al., 2010).  In these studies, up to 60 % of dietary FO could be replaced by 358 
linseed oil without affecting growth, but higher levels of replacement could reduce growth 359 
dependent upon species, fish size and duration of feeding (Izquierdo et al., 2003; Regost et al., 360 
2003; Menoyo et al., 2004; Mourente et al., 2005; Piedecausa et al., 2007). There are no previous 361 
studies reporting the effects of CO in marine fish but, in the only study reported to date, growth 362 
of Atlantic salmon smolts was not affected by feeding a diet with 100% of FO replaced with a 363 
VO blend containing rapeseed, palm and Camelina oils in a 5:3:2 ratio (Bell et al., 2010).  364 
      The effects of dietary CO on tissue fatty acid composition in cod were as expected 365 
considering the extensive data in the literature describing the effects of VO in fish, with increased 366 
C18 fatty acids, including 18:0, 18:1n-9, LOA and ALA, and decreased levels of EPA and DHA 367 
(Turchini et al., 2010). In the only trials to date utilizing CO, the fatty acid composition of liver in 368 
Atlantic salmon fed a VO blend containing CO was characterized by increased levels of ALA 369 
and its elongation product 20:3n-3, but decreased levels of all other n-3 fatty acids (Petropoulos 370 
et al., 2009; Bell et al., 2010). The data in the present study with cod and CO are comparable with 371 
the data obtained in other marine fish species fed ALA-rich oils (Tocher et al., 2010). Studies 372 
feeding linseed oil to sea bass, turbot, gilthead and sharpsnout sea bream all showed increased 373 
percentages of ALA, LOA and their elongation products, 20:3n-3 and 20:2n-6, and decreased 374 
proportions of EPA, DHA and ARA and no increased percentages of any desaturated 375 
intermediates such as 18:4n-3, 20:4n-3, 18:3n-6 or 20:3n-6 in tissue lipids (Izquierdo et al., 2003; 376 
Regost et al., 2003; Menoyo et al., 2004; Mourente et al., 2005; Piedecausa et al., 2007). 377 
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Therefore, provision of ALA substrate was not able to compensate for the lack of LC-PUFA in 378 
the diet of marine fish and there was little evidence of any significant desaturation of dietary 379 
ALA. Although feeding high levels of CO did not prevent reductions in EPA and DHA compared 380 
to fish fed FO, the increased levels of ALA in flesh are useful as it is also recognized as an 381 
essential fatty acid in human nutrition (Burdge, 2006; Brenna et al., 2009). The human diet is 382 
imbalanced with overly high n-6/n-3 ratios, particularly in the developed countries (Simopoulos, 383 
2006) and, although production of fish containing high levels of EPA and DHA should be a 384 
major goal in aquaculture, a product with a high n-3/n-6 ratio is still desirable even if some of the 385 
n-3 PUFA is ALA rather than EPA and DHA. In comparison to EPA and DHA, ALA is inferior 386 
as a component of fish flesh, but it is preferable to LOA (Whelan, 2008). 387 
In order to directly address the question of whether cod have the capacity to up-regulate the 388 
LC-PUFA biosynthesis pathway in response to increasing levels of CO, the expression of fatty 389 
acyl desaturase (Δ6fad) and elongase (elovl5) genes, which have been shown to be 390 
transcriptionally regulated, and correlated with enzymatic activity, in Atlantic salmon (Zheng et 391 
al., 2004, 2005), was measured by RT-qPCR. Results in both liver and intestine showed no 392 
significant nutritional regulation of elovl5 in cod fed CO. In liver, a trend for higher Δ6fad 393 
expression in the two treatments with higher levels of FO replacement, particularly C66, in 394 
comparison to the C0 diet was noticeable, but biological variability of the data was high and the 395 
results were not significant. A previous study on the nutritional regulation of these genes in cod 396 
showed that dietary FO replacement by VO tended to increase the expression of both Δ6fad and 397 
elovl5 in hepatocytes and enterocytes, but there was high biological variability and so only elovl5 398 
in enterocytes was significant, although there was no significant effect on LC-PUFA biosynthesis 399 
enzyme activities in either tissue (Tocher et al., 2006). In the case of Δ6fad, this is likely due to 400 
lower basal expression of this gene, compared to salmon, perhaps associated with lower activity 401 
of the cod Δ6fad promoter (Zheng et al., 2009).     402 
Recent studies have begun to investigate the molecular effects of alternative diet formulations, 403 
and hepatic responses to feeds containing high levels of replacement of FO by VOs are being 404 
characterized (Panserat et al., 2009; Morais et al., 2011a,b). However, studies on the intestinal 405 
transcriptome in fish have mainly focused on replacement of fishmeal by plant proteins, in 406 
particular soybean meal, given its potential to cause enteritis in some species (Murray et al., 407 
2010; Skugor et al., 2011). Furthermore, the majority of these transcriptomic studies have been 408 
conducted on salmonid species, which can tolerate high levels of fishmeal and FO replacement 409 
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(Turchini et al., 2010; Hardy, 2010), whereas few data exist for marine species. Here we 410 
examined the effects of CO on the intestinal transcriptome of cod. This knowledge is important 411 
as it is well established that the intestine is more than simply the site of nutrient uptake, and that 412 
enterocytes are also sites of significant lipid metabolism (Tocher et al., 2002; Bell et al., 2003). 413 
For example, despite LC-PUFA biosynthesis ability being low in cod, the activity of this pathway 414 
was around 7-fold higher in enterocytes than in hepatocytes (Tocher et al., 2006). In addition, the 415 
intestine has a vital role in protecting against the entry of pathogens and is one of the largest 416 
immune organs in the body. Hence, its proper function is essential for maintaining optimal 417 
balance and health and can be significantly affected by replacing dietary FO by VO, 418 
accompanied by reductions in n-3/n-6 LC-PUFA ratios (Teitelbaum and Walker, 2001).  419 
The microarray analysis identified translation, cell proliferation or differentiation and 420 
apoptosis, as well as structural molecules, as the biological categories in cod intestine most 421 
highly affected by dietary CO. Surprisingly, lipid metabolism and metabolism in general were 422 
little affected by changes in diet formulation, changes that were exclusively in lipid composition. 423 
The main observed effect was up-regulation of apoA-IV in the intestine of cod fed the C66 diet. 424 
In humans and rodents this protein is mainly found free in plasma but is also a major component 425 
of chylomicrons and very low density lipoproteins (VLDL) and is synthesized by enterocytes in 426 
the small intestine (Green and Glickman, 1981). In mammals, apoA-IV is the only apolipoprotein 427 
that showed a marked response to intestinal absorption and transport of lipid, through increased 428 
expression, synthesis and secretion (Kalogeris et al., 1997; Tso et al., 2001). A commonly 429 
reported effect of the inclusion of VO in the diet of carnivorous fish is an accumulation of lipid 430 
droplets in the enterocytes, which might be explained by a reduction in LC-PUFA levels leading 431 
to changes in re-acylation mechanisms and phospholipid synthesis rates and consequent lower 432 
lipoprotein assembly and export from intestinal cells (Caballero et al., 2003; Olsen et al., 2003). 433 
However, apoA-IV is one of the least well characterized apolipoproteins in fish species and there 434 
is no information regarding its physiological function. Furthermore, even in mammals, apoA-IV 435 
has diverse roles, including the regulation of appetite and gastrointestinal function (enzyme 436 
secretion and gastric emptying), and displays anti-oxidant and anti-atherogenic properties in 437 
rodents (Kalogeris et al., 1997; Tso et al., 2001; Stan et al., 2003). The biochemical results 438 
showed a trend for higher lipid content in fish fed the diets containing CO, and intestinal lipid 439 
was significantly higher in fish fed C66 compared to C0. Hence, although other factors might 440 
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explain the changes in apoA-IV expression, they may be related to effects of dietary lipid 441 
composition on lipid absorption and transport. 442 
A large number of ribosomal proteins were slightly, but consistently, down-regulated in the 443 
intestine of cod fed the CO diet. Ribosomal proteins typically show a highly coordinated 444 
response in terms of expression changes in salmon microarrays and Skugor et al. (2011) reported 445 
increased expression in a number of these in response to cellular stressors. However, RT-qPCR 446 
did not confirm the microarray data, preventing firm conclusions on potential effects of diet on 447 
translation. In contrast, good agreement was obtained between the microarray and RT-qPCR 448 
results for some genes involved in cell proliferation or differentiation and apoptosis with rarres3 449 
and casp being 7.8- and 1.9-fold up-regulated, respectively, in the intestine of cod fed the C66 450 
diet. Retinoic acid receptor responder protein 3 (rarres3), also known as retinoid-inducible gene 451 
1 protein or tazarotene-induced gene 3, is a nuclear receptor and transcriptional regulator that is 452 
thought to act as a tumour suppressor, regulating growth and differentiation of many cell types, 453 
mediated via inhibition of cellular growth (G0/G1 arrest) or induction of apoptosis (DiSepio et 454 
al., 1998; Huang et al., 2000). The strong up-regulation of this transcript in the intestine of cod 455 
fed CO is thus likely reflected in lower cellular proliferation. Furthermore, up-regulation of casp 456 
in cod fed CO indicates increased apoptosis and hence possibly also lower intestinal tissue 457 
growth.  458 
Other transcripts that were up-regulated (in the top100 most significant list) in the CO 459 
treatment were tumor protein p63 regulated 1 (tprg1l), 40S ribosomal protein SA (rpsa), origin 460 
recognition complex subunit 2-like and voltage-dependent anion-selective channel protein 1. The 461 
p63 tumor protein is a transcription factor that is highly expressed in basal cells of epithelial 462 
layers in mammals, and at least some of its variants have effects on induction of apoptosis and 463 
arresting growth (Yang et al., 1998; Wu et al., 2003). The origin recognition complex is essential 464 
for the initiation of DNA replication and heterochromatin assembly in eukaryotic cells, ensuring 465 
tight regulation of the cell cycle and preventing re-replication of DNA during a single cell 466 
division cycle. This may suggest tighter control of replication in the intestine of cod fed the CO 467 
diet, although this complex has other non-replication roles (Chesnokov, 2007; Sasaki and Gilbert, 468 
2007). Voltage-dependent anion-selective channel protein 1 is also associated with regulation of 469 
cell growth and death, interacting with several pre- or anti-apoptotic proteins to allow the 470 
formation of pores in outer mitochondrial and plasma membranes, affecting their permeability. 471 
When the channel adopts an open conformation it enables cytochrome c release into the cytosol, 472 
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which triggers caspase activation and apoptosis (Shoshan-Barmatz et al., 2006). In addition, 473 
down-regulation of proline-rich protein BCA3-like and translationally-controlled tumor protein 474 
homolog (tctp) might indicate lower cell proliferation in intestine of cod fed CO. Proline-rich 475 
protein BCA3-like is over-expressed tumor cell lines while normal tissues have low levels of 476 
expression (Kitching et al., 2003). Several features coding for tctp were down-regulated in the 477 
microarray results, confirmed by RT-qPCR. This protein is important for microtubule 478 
stabilization and was up-regulated in several tumours (Hsu et al., 2007), and reduction of its level 479 
can induce tumour reversion, and spatial distribution of tctp expression in Hydra correlated with 480 
regions of active cell proliferation (Yan et al., 2000), all indicating an important role in cell 481 
growth and proliferation (Tuynder et al., 2004).   482 
The data therefore suggest a hypothesis of lower cell proliferation and/or higher apoptosis in 483 
intestine of cod fed diet C66. Gastrointestinal cell proliferation and apoptosis were previously 484 
found to be significantly reduced in Atlantic salmon when VO replaced dietary FO (Olsvik et al., 485 
2007). Although the cell’s normal renewal capacity could have been impaired after a period of 486 
potentially adverse intestinal conditions when feeding VO, given that lower transcription was 487 
also measured for genes related to cellular and oxidative stress, the authors attributed their results 488 
to reduced oxidative stress associated with lower levels of LC-PUFA in intestinal membranes of 489 
fish fed VO (Olsvik et al., 2007). This would result in lower potential for lipid peroxidation and 490 
production of reactive oxygen species (ROS), which are important signalling molecules in 491 
apoptotic processes (Ramachandran et al., 2000). In the present study the evidence, albeit 492 
circumstantial, collectively supports the concept of reduced cellular proliferation and increased 493 
apoptosis in the intestine of fish fed CO, compared to those fed the FO diet. Furthermore, results 494 
from GO analysis identified several categories of biological processes broadly related to 495 
development, cell differentiation and cytoskeleton organization, which indicate potential effects 496 
of VO on intestinal regenerative processes or repair, but this requires further investigation.    497 
In addition to a high preponderance of structural proteins in the list of genes showing 498 
significant effects of diet, GO analysis identified actin-binding as one of the molecular function 499 
categories that was over-represented. Genes in this functional category included tropomyosin 500 
alpha-1 chain, myosin heavy chain, actin alpha cardiac muscle 1, cofilin 1, ectodermal-neural 501 
cortex and transgelin, which were 1.4- to 1.8-fold up-regulated (except actin, which was 1.2-fold 502 
down-regulated) in cod fed diet C66. Changes in the expression of these genes indicate likely 503 
modifications in the structural composition of smooth muscle, possibly affecting contractile 504 
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activity or motility of the intestine. Genes with similar biological function, including tropomyosin 505 
and myosin, were down-regulated in Atlantic halibut intestine in response to partial soybean meal 506 
replacement of fishmeal (Murray et al., 2010). In that study, genes coding for structural proteins 507 
were regulated in a coordinated matter with others involved in muscle physiology, such as 508 
creatine kinase (CK), which was also the case here, even if opposite changes were observed, 509 
indicating potentially conflicting effects of fishmeal and FO replacement in these two species. 510 
Creatine kinase has a key role in muscle energetic metabolism and CK activity relates to the 511 
oxidative capacity as well as contractile characteristics of muscle (Clark, 1994). Changes in CK 512 
activity and expression level are diagnostic markers for conditions involving muscle damage in 513 
mammals, including intestinal infarction or ischemia (Fried et al., 1991; Block et al., 2011). 514 
Furthermore, skeletal muscle atrophy has been associated with variations in gene expression 515 
profiles similar to those observed here, namely up-regulation of M-type CK as well as of fast-516 
type isoforms of myosin heavy chains (Cros et al., 1999). These effects could not have been 517 
anticipated and, unfortunately, no samples were collected for histological analysis preventing 518 
gene expression to be related to intestinal morphology.   519 
In summary, CO may be a useful more sustainable alternative for the replacement of FO in the 520 
diets of Atlantic cod. Replacement of FO by CO did not induce major metabolic changes in 521 
intestinal tissue, as might have been expected, but rather potentially affected rates of cellular 522 
proliferation and death, and changes in the structural properties of the intestinal muscle, most 523 
likely leading to different rates of tissue regeneration and/or repair, as well as potential changes 524 
in contractile activity or mechanical characteristics. The underlying molecular mechanisms 525 
explaining these effects on gene expression cannot be determined conclusively but, considering 526 
the important role of the intestine in nutrient absorption and whole body balance and health, 527 
further attention should be given to this organ in future studies examining effects of FO 528 
replacement by VO.  529 
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Supplementary data: Features present in the following categories of biological process, all 537 
found to be significantly enriched by GO analysis: “multicellular organismal development” 538 
(adjusted p-value: 0.002), “anatomical structural development” (adjusted p-value: 0.003), 539 
“developmental process” (adjusted p-value: 0.006), “epidermal cell differentiation” (adjusted p-540 
value: 0.031), and “regulation of cytoskeleton organization” (adjusted p-value: 0.01). Shown are 541 
fold changes in cod intestine between diets C66 and C0. 542 
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Figure Captions 789 
 790 
Fig. 1. Expression, measured by RT-qPCR, of fatty acyl elongase (elovl5) and desaturase (Δ6fad) 791 
genes in Atlantic cod intestine (A) and liver (B) tissues. Results are normalised expression ratios 792 
(average of n=6 ± SE) of the expression of these genes in fish fed each one of the diets containing 793 
Camelina oil, in relation to those fed diet C0 (100% FO). 794 
 795 
Fig. 2. Distribution by categories of biological function of genes found to be differentially 796 
expressed in the intestine between cod fed diets C0 and C66 (Welch t-test, p<0.05; 1.2 fold 797 
change cut-off). Non-annotated genes (36% of a total of 289 features) and features corresponding 798 
to the same gene are not represented. 799 
 800 
801 
27 
 
Table 1  801 
Formulations (g/Kg) and proximate composition (percentage of total weight) of diets containing 802 
increasing levels of Camelina oil.   803 
Component                                     C0                    C33                      C66                   C100  804 
1Fish meal                                  610.6                  610.6                    610.6                  610.6  805 
1Soya meal                                    150                     150                       150                     150                   806 
1Wheat                                            65                       65                         65                       65                   807 
2Krill meal                                      50                       50                         50                       50                   808 
1Northern Fish oil                           80                    53.6                      27.2                         0                   809 
3Camelina oil                                    0                    26.4                      52.8                       80                   810 
4Vitamin mix comp                        10                       10                         10                       10                     811 
5Mineral mix (M2)                          24                       24                         24                       24                   812 
6Carboxymethyl cellulose              10                        10                         10                       10                     813 
7Antioxidant mix                           0.4                       0.4                        0.4                     0.4      814 
Proximate composition 815 
Protein                                         54.9                      55.5                     55.0                    53.3 816 
Lipid                                            14.2                      15.3                     14.6                    14.3 817 
Moisture                                        9.3                        7.2                       8.1                      6.8 818 
Ash                                              10.6                      10.7                     10.4                    10.6               819 
 820 
C0, control diet containing 100% fish oil. C33, C66 and C100, diets containing 33%, 66% and 821 
100% Camelina oil as a replacement for fish oil,  822 
1Ewos Ltd, Bathgate, UK. 2Aker Biomarine, Norway. 3Technology Crops International Inc., 823 
USA. 4Contains g/kg diet, Vitamin A, 2500 IU; Vitamin D, 2400 IU; Vitamin E, 100; Vitamin K, 824 
10; Ascorbic acid 1000; Thiamin, 10; Riboflavin, 20; Pyridoxine, 12; Pantothenic acid, 44; 825 
Nicotinic acid, 150; Biotin, 1; Folic acid, 5; Vitamin B12, 0.02; myo-inositol, 400; Choline 826 
Chloride, 3. 5 Contains g/kg diet or as stated, KH2PO4, 22; FeSO4.7H2O; 1.0; ZnSO4.7H2O, 0.13; 827 
CuSO45H2O, 12 mg/kg; MnSO4.4H2O, 53 mg/kg; KI, 2 mg/kg; CoSO4.7H2O, 2 mg/kg; α-828 
cellulose, 0.8; 6Sigma-Aldrich Ltd, Gillingham, UK. 7 Contains g/L; Butylated hydroxyanisole, 829 
60; Propyl gallate, 60; Citric acid, 40; in propylene glycol, added at 0.4g/kg diet. 830 
831 
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Table 2  831 
Fatty acid compositions (percentage of weight of total fatty acids) of experimental diets.  832 
 833 
                                                    C0                   C33                 C66                  C100 834 
___________________________________________________________________________ 835 
 836 
14:0                                             5.5                    4.6                    3.6                     2.5   837 
16:0                                           13.6                  12.8                  11.9                   10.9    838 
18:0                                             1.9                    2.1                    2.5                     2.7 839 
Total saturates1                                      22.1                  20.8                  19.3                   17.4   840 
16:1n-7                                        6.3                    5.4                    4.2                     2.1 841 
18:1n-9                                        9.3                  10.5                  11.5                   12.2 842 
18:1n-7                                        2.5                    2.3                    2.0                     1.6 843 
20:12                                          11.6                  11.6                  11.5                   11.2 844 
22:13                                          16.3                  13.3                  10.0                     6.6 845 
24:1                                             0.9                    0.9                    0.8                     0.8  846 
Total monoenes4                        49.2                  45.6                  41.3                   36.4 847 
18:2n-6                                        3.5                    5.7                    8.6                   11.6 848 
20:2n-6                                        0.3                    0.5                    0.9                     1.2 849 
20:4n-6                                        0.4                    0.4                    0.3                     0.3 850 
Total n-65                                    4.4                    6.9                    9.9                   13.1    851 
18:3n-3                                        1.2                    6.4                  12.6                   18.7 852 
18:4n-3                                        3.3                    2.8                    2.2                     1.6  853 
20:3n-3                                        0.1                    0.3                    0.6                     0.8 854 
20:4n-3                                        0.5                    0.4                    0.3                     0.3 855 
20:5n-3                                        8.4                    7.2                    5.8                     4.6 856 
22:5n-3                                        0.7                    0.6                    0.5                     0.4           857 
22:6n-3                                        9.0                    8.1                    6.9                     6.2 858 
Total n-3                                    23.0                  26.4                  28.7                   32.6    859 
n-3/n-6 PUFA                              5.2                    3.8                    2.9                     2.5 860 
Total PUFA6                               28.7                  33.7                  39.4                   46.2 861 
______________________________________________________________________________ 862 
 863 
1Includes 15:0, 17:0 and 20:0. 2Includes both 20:1n-9 and 20:1n-7; 3Includes both 22:1n-11 and 864 
22:1n-9; 4Includes 14:1n-5 and 16:1n-9; 5Includes 18:3n-6, 20:3n-6, 22:4n-6 and 22:5n-6; 865 
6Includes C16 PUFA. 866 
867 
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 867 
Table 3  868 
Primers used for RT-qPCR analyses.  869 
 870 
Transcript Primer sequence (5’-3’) Fragment Ta Accession No./Contig  
Δ6fad AGGCACAACTACCAGGTGCT 117 bp 60 ºC DQ0548401 
 CTTAAGCGACCGCACGAC    
elovl5 ACTGCCAAGACACACACAGC 163 bp 56 ºC GW8482981 
 CTGGCGTGATGGTAGATGTG    
elf1a GTGATCAAGAGCGTCGACAA 189 bp 60 ºC CL5Contig22 
 GATGCGCATTAACCAGTCCT    
rpl13 TCAGGTGTCCAACCATCAGA 249 bp 60 ºC CL81Contig12 
 CCTCAGTGCTGTCTCCCTTC    
etf3f GCCACCGTTCTCACCTACAT 186 bp 60 ºC CL224Contig12 
 TTGGGTGAGGTTGGACAAAT    
tprg1l TTGTCGAGCCTCTCCTGTCT 207 bp 60 ºC CL553Contig12 
 GCTCGCCGACTTAACAACTC    
rarres3 ATCTACCATGGCCCCAACTT 174 bp 60 ºC CL2455Contig12 
 ACAACGGCACAGGAACTGTC    
rpsa GCTGACCAGAGAGGTTCTGC 162 bp 60 ºC CL97Contig12 
 CACTCAGCCTGGAACTCCTC    
tctp TTTTTCATCGAGGTGGAAGG 248 bp 60 ºC CL18Contig12 
 CTCTCTGGCTTGGTCTCCTG    
casp3 AGCTGATGCAGATCATGACG 216 bp 60 ºC CL1129Contig12 
 TTTCCTCAGCACCCGTAGTT    
tpm CCGCTTAGCGTTCAGTTAGG 158 bp 60 ºC CL54Contig12 
 GCTCTGTCCAAGGCATTCTC    
tekt4 ATTACGCGATCCTCCAACAG 176 bp 60 ºC CL1914Contig12 
 CTGCAACTCCGACTTCAACA    
cdh3 CCTGCCAATCCTGAAGACAT 152 bp 60 ºC CE2051-2005-02- 
 GAGGAGTTGAGGGACGACAG   15.ab12 
     
Reference genes    
bact CTACGAGGGGTATGCTCTGC 123 bp 56 ºC AJ5554631 
 CTCTCAGCAGTGGTGGTGAA    
ubq3 GGCCGCAAAGATGCAGAT 69 bp 60 ºC EX7356131 
 CTGGGCTCGACCTCAAGAGT    
gapdh3 CCATGACAACTTTGGCATCGT 83 bp 60 ºC EX7255661 
 AGGGTCCGTCCACTGTCTTCT    
1 GenBank Accession No (http://www.ncbi.nlm.nih.gov/) 871 
2 Contig in microarray (based on an assembly of cod ESTs; ArrayExpress: E-TABM-1178) 872 
3 Olsvik et al. (2008) 873 
 874 
875 
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 Table 4 875 
Growth, feed efficiency and biometry of Atlantic cod fed diets containing increasing proportions 876 
of Camelina oil. 877 
 878 
Columns with different letters are significantly different (P < 0.05). 879 
880 
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Table 5  880 
Fatty acid compositions (percentage weight of total fatty acids) of cod liver after feeding diets 881 
containing increasing levels of Camelina oil. 882 
 883 
                                           C0                         C33                          C66                        C100 884 
______________________________________________________________________________ 885 
14:0                               3.7 ± 0.1a                3.1 ± 0.1b                  2.4 ± 0.1c               1.7 ± 0.0d 886 
16:0                             12.4 ± 0.3a              11.6 ± 0.3ab               10.4 ± 0.3bc              9.7 ± 0.9c    887 
18:0                               2.7 ± 0.1                 3.0 ± 0.1                    2.9 ± 0.3                2.9 ± 0.2 888 
Total saturates1                 19.6 ± 0.3a              18.3 ± 0.4a                        16.4 ± 0.5b             15.0 ± 0.8c   889 
16:1n-7                         6.4 ± 0.2a                        5.6 ± 0.1b                  4.4 ± 0.1c                3.5 ± 0.4d 890 
18:1n-9                       15.9 ± 0.4b                     16.5 ± 0.5ab               17.1 ± 0.6ab             17.4 ± 0.5a   891 
18:1n-7                         4.1 ± 0.1a                        3.8 ± 0.1a                           3.2 ± 0.1b                2.7 ± 0.3c 892 
20:12                           12.0 ± 0.4a                     11.3 ± 0.5ab               10.7 ± 0.2bc             10.1 ± 0.3c 893 
22:13                             8.9 ± 0.1a                        6.8 ± 0.4b                  4.8 ± 0.2c                3.0 ± 0.2d 894 
24:1                              0.5 ± 0.0                  0.5 ± 0.0                   0.4 ± 0.0                  0.5 ± 0.2  895 
Total monoenes4             50.6 ± 0.4a              46.7 ± 0.4b                42.6 ± 0.3c              39.0 ± 1.0d 896 
18:2n-6                         3.9 ± 0.1d                6.3 ± 0.1c                  9.3 ± 0.4b               12.0 ± 0.2a 897 
20:2n-6                         0.5 ± 0.0d                0.8 ± 0.1c                  1.2 ± 0.1b                 1.6 ± 0.1a     898 
20:4n-6                         0.4 ± 0.1                  0.4 ± 0.0                   0.3 ± 0.0                  0.3 ± 0.1 899 
Total n-6 PUFA5          5.2 ± 0.1d                 7.8 ± 0.2c                11.1 ± 0.4b               14.2 ± 0.3a   900 
18:3n-3                         1.3 ± 0.1d                6.5 ± 0.2c                 12.7 ± 0.6b               18.0 ± 0.7a 901 
18:4n-3                         3.0 ± 0.1a                        2.7 ± 0.1b                   2.2 ± 0.1c                 1.6 ± 0.1d  902 
20:3n-3                         0.2 ± 0.0d                 0.5 ± 0.0c                   0.8 ± 0.0b                 1.1 ± 0.0a 903 
20:4n-3                         0.8 ± 0.1a                        0.6 ± 0.0b                   0.5 ± 0.0bc                0.4 ± 0.0c 904 
20:5n-3                         8.7 ± 0.2a                        7.5 ± 0.3b                   6.1 ± 0.2c                  4.6 ± 0.3d 905 
22:5n-3                         0.9 ± 0.0a                        0.8 ± 0.0a                   0.6 ± 0.0b                  0.5 ± 0.0b  906 
22:6n-3                         8.9 ± 0.3a                        7.7 ± 0.2b                   6.3 ± 0.5c                  5.2 ± 0.2d 907 
Total n-3 PUFA          23.7 ± 0.6d              26.3 ± 0.6c                 29.1 ± 0.6b                31.3 ± 1.1a    908 
n-3/n-6 PUFA               4.4 ± 0.3a                       3.3 ± 0.3b                   2.6 ± 0.4bc                 2.2 ± 0.6c 909 
Total PUFA6               29.8 ± 0.7d              35.0 ± 0.7c                 41.0 ± 0.7b                46.0 ± 1.2a 910 
______________________________________________________________________________     911 
Values are means ± SD (n = 3). Columns with different letters are significantly different (P < 912 
0.05). 1Includes 15:0, 17:0 and 20:0. 2Includes both 20:1n-9 and 20:1n-7; 3Includes both 22:1n-11 913 
and 22:1n-9; 4Includes 14:1n-5 and 16:1n-9; 5Includes 18:3n-6, 20:3n-6, 22:4n-6 and 22:5n-6; 914 
6Includes C16 PUFA. 915 
 916 
 917 
918 
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 918 
 919 
Table 6  920 
Fatty acid composition (percentage weight of total fatty acids) of cod intestine after feeding diets 921 
containing increasing levels of Camelina oil. 922 
 923 
                                           C0                         C33                          C66                        C100 924 
______________________________________________________________________________ 925 
14:0                               2.1 ± 0.6                 2.5 ± 0.2                  2.1 ± 0.1                   1.7 ± 0.1 926 
16:0                             14.6 ± 0.4a              13.4 ± 0.1b               12.5 ± 0.2bc              12.0 ± 0.7c    927 
18:0                               4.0 ± 0.5                 3.4 ± 0.1                  3.6 ± 0.2                   3.7 ± 0.3 928 
Total saturates1                 21.6 ± 0.2a              20.2 ± 0.2ab              18.9 ± 0.3bc              18.4 ± 1.3c   929 
16:1n-7                         3.2 ± 0.5ab               3.6 ± 0.2a                 3.1 ± 0.2ab                2.5 ± 0.2b 930 
18:1n-9                       11.2 ± 0.1b               11.2 ± 0.6b               12.2 ± 0.5ab              12.7 ± 0.5a   931 
18:1n-7                         2.8 ± 0.2a                 2.7 ± 0.1a                 2.3 ± 0.1b                 1.8 ± 0.1c 932 
20:12                             6.8 ± 0.7b                 7.8 ± 0.3ab               8.1 ± 0.1a                  8.2 ± 0.5a 933 
22:13                             4.7 ± 1.9                  4.9 ± 0.8                  4.0 ± 0.2                   3.3 ± 0.4 934 
24:1                              2.2 ± 0.2                  1.8 ± 0.2                  1.7 ± 0.2                   2.0 ± 0.5  935 
Total monoenes4             31.2 ± 2.7                32.3 ± 0.8                31.7 ± 0.4                 30.9 ± 1.4 936 
18:2n-6                         2.7 ± 1.0d                 4.5 ± 0.2c                 6.9 ± 0.2b                 9.4 ± 0.7a 937 
20:2n-6                         0.5 ± 0.0d                 0.9 ± 0.1c                 1.3 ± 0.1b                 1.6 ± 0.0a     938 
20:4n-6                         1.7 ± 0.2a                 1.2 ± 0.1b                 1.0 ± 0.1b                 0.9 ± 0.1b 939 
Total n-6 PUFA5          5.4 ± 0.8d                 7.0 ± 0.1c                 9.6 ± 0.1b               12.3 ± 0.7a   940 
18:3n-3                         0.8 ± 0.3d                 4.1 ± 0.3c                 8.5 ± 0.4b               12.5 ± 1.3a 941 
18:4n-3                         1.2 ± 0.4                  1.5 ± 0.2                  1.3 ± 0.1                   1.0 ± 0.1  942 
20:3n-3                         0.1 ± 0.0d                 0.4 ± 0.0c                 0.7 ± 0.0b                 1.0 ± 0.2d 943 
20:4n-3                         0.5 ± 0.0a                 0.6 ± 0.0a                 0.5 ± 0.1a                 0.3 ± 0.1b 944 
20:5n-3                       10.1 ± 0.3a                 9.9 ± 0.3a                 8.4 ± 0.2b                 6.8 ± 0.3c 945 
22:5n-3                         1.2 ± 0.1a                 1.0 ± 0.1ab                0.8 ± 0.1bc               0.7 ± 0.0c  946 
22:6n-3                       24.1 ± 3.9a               18.9 ± 1.4ab              16.3 ± 0.5b              13.9 ± 0.9b 947 
Total n-3 PUFA         38.0 ± 3.7                 36.5 ± 1.3                36.5 ± 0.3                36.3 ± 1.5    948 
n-3/n-6 PUFA              7.2 ± 1.8a                  5.2 ± 0.2a                 3.8 ± 0.1b                2.9 ± 0.1c 949 
Total PUFA6              44.1 ± 2.9b                44.2 ± 1.3ab             46.8 ± 0.3ab             49.0 ± 2.1a 950 
______________________________________________________________________________     951 
Values are means ± SD (n = 3). Columns with different letters are significantly different (P < 952 
0.05). 1Includes 15:0, 17:0 and 20:0. 2Includes both 20:1n-9 and 20:1n-7; 3Includes both 22:1n-11 953 
and 22:1n-9; 4Includes 14:1n-5 and 16:1n-9; 5Includes 18:3n-6, 20:3n-6, 22:4n-6 and 22:5n-6; 954 
6Includes C16 PUFA. 955 
 956 
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Table 7  957 
Fatty acid compositions (percentage weight of total fatty acids) of cod muscle after feeding diets 958 
containing increasing levels of Camelina oil. 959 
 960 
                                            C0                          C33                        C66                        C100 961 
______________________________________________________________________________ 962 
14:0                                1.6 ± 0.0a                 1.7 ± 0.4a               1.5 ± 0.1ab               1.0 ± 0.2b 963 
16:0                              15.8 ± 0.5a               14.5 ± 1.2ab            14.9 ± 1.0ab             13.2 ± 0.4b    964 
18:0                                3.3 ± 0.1                  3.3 ± 0.3                 4.1 ± 0.8                 3.6 ± 0.2 965 
Total saturates1                  21.7 ± 0.4a               19.8 ± 1.0ab             20.4 ± 1.5ab            18.2 ± 0.6b   966 
16:1n-7                          2.8 ± 0.0a                 2.6 ± 0.3a                 2.1 ± 0.1b               1.6 ± 0.2c 967 
18:1n-9                        11.4 ± 1.4                11.3 ± 0.9                11.3 ± 0.7               11.2 ± 0.7   968 
18:1n-7                          3.2 ± 0.2a                 2.8 ± 0.1b                2.5 ± 0.1bc               2.2 ± 0.1c 969 
20:12                              4.5 ± 0.1                  5.1 ± 1.0                 4.5 ± 0.2                  4.5 ± 0.2 970 
22:13                              2.3 ± 0.2ab                2.6 ± 0.7a               1.7 ± 0.5ab                1.4 ± 0.1b 971 
24:1                               0.7 ± 0.1                   0.8 ± 0.1                0.9 ± 0.1                   0.8 ± 0.1  972 
Total monoenes4             26.7 ± 2.2                 27.0 ± 3.5               24.5 ± 1.3                 22.7 ± 1.3 973 
18:2n-6                         3.0 ± 0.1d                  4.8 ± 0.3c                6.6 ± 0.4b                 8.8 ± 0.3a 974 
20:2n-6                         0.4 ± 0.0d                  0.7 ± 0.0c                1.0 ± 0.1b                 1.4 ± 0.0a     975 
20:4n-6                         1.1 ± 0.1                   1.1 ± 0.2                  1.1 ± 0.0                  1.1 ± 0.1 976 
Total n-6 PUFA5          5.0 ± 0.2d                  7.3 ± 0.2c                 9.3 ± 0.4b              11.9 ± 0.3a   977 
18:3n-3                         0.9 ± 0.0d                  4.3 ± 0.7c                 7.5 ± 0.4b              11.0 ± 0.7a 978 
18:4n-3                         1.5 ± 0.2a                  1.4 ± 0.4ab                1.1 ± 0.1ab              0.8 ± 0.1b  979 
20:3n-3                         0.1 ± 0.0d                  0.4 ± 0.0c                  0.7 ± 0.0b              1.0 ± 0.0a 980 
20:4n-3                         0.7 ± 0.0a                  0.6 ± 0.0ab                 0.5 ± 0.0ab             0.4 ± 0.0b 981 
20:5n-3                       14.5 ± 1.6a                13.5 ± 0.9a                11.9 ± 0.4ab           10.8 ± 0.7b 982 
22:5n-3                         1.6 ± 0.2                   1.5 ± 0.2                    1.3 ± 0.0               1.3 ± 0.1           983 
22:6n-3                       25.5 ± 3.8                 23.4 ± 2.7                  21.7 ± 1.0              21.3 ± 1.4 984 
Total n-3 PUFA         43.1 ± 4.4                  44.9 ± 3.3                  44.7 ± 1.0              46.6 ± 1.8    985 
n-3/n-6 PUFA               8.6 ± 2.1a                  6.2 ± 1.1ab                 4.8 ± 0.7b               3.9 ± 0.8b 986 
Total PUFA6               50.3 ± 5.1                 52.6 ± 3.2                  54.3 ± 1.1              58.6 ± 1.8 987 
_____________________________________________________________________________     988 
 989 
Values are means ± SD (n = 3). Columns with different letters are significantly different (P < 990 
0.05). 1Includes 15:0, 17:0 and 20:0. 2Includes both 20:1n-9 and 20:1n-7; 3Includes both 22:1n-11 991 
and 22:1n-9; 4Includes 14:1n-5 and 16:1n-9; 5Includes 18:3n-6, 20:3n-6, 22:4n-6 and 22:5n-6; 992 
6Includes C16 PUFA. 993 
994 
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Table 8  994 
Transcripts corresponding to the top 100 most significant features exhibiting differential 995 
expression in cod intestine between diets C0 and C66 (fold change given as C66 / C0). Annotated 996 
features (66%) are arranged by categories of biological function and, within these, by decreasing 997 
significance (p-value, assessed by Welch t-test). Indicated is also the percentage of gene 998 
distribution by functional categories, after removing features representing the same gene.  999 
Probe No. Accession 
No. 
SwissProt Annotation Fold change 
(C66/C0) 
p-value 
Lipid metabolism (5%)   
CE2148 GO377376 Apolipoprotein A-IV 1.48 0.0018 
CPY1052 GO387010 Apolipoprotein A-IV 1.50 0.0034 
CPY442 GO387753 Apolipoprotein A-IV 1.53 0.0048 
CPY1606 GO387357 Apolipoprotein A-IV 1.51 0.0049 
CPY1409 GO387232 Apolipoprotein A-IV 1.54 0.0057 
CPY465 GW857638 Apolipoprotein A-IV 1.50 0.0057 
CHY224 GO383431 Apolipoprotein A-IV 1.59 0.0057 
CPY1627 GO387370 Apolipoprotein A-IV 1.45 0.0064 
CLE718 GW849678 Lipovitellin-2 - 1.21 0.0098 
CE1608 GW843824 Apolipoprotein A-IV 1.53 0.0075 
CPY225 GO387561 Apolipoprotein A-IV 1.48 0.0104 
CPY205 GO387527 Apolipoprotein A-IV 1.40 0.0141 
CTA293 N/A Apolipoprotein A-IV 1.51 0.0161 
     
Energy metabolism (5%)   
CHO292 GO382345 Creatine kinase B-type 1.62 0.0104 
CE1110 GO376622 Creatine kinase B-type 1.59 0.0138 
CTA327 GO390332 Creatine kinase B-type 1.37 0.0146 
CE2531 GW843201 Creatine kinase M-type 1.28 0.0152 
CTE1039 GO390859 Creatine kinase B-type 1.51 0.0174 
CTE1378 GW861048 Creatine kinase B-type 1.60 0.0178 
     
Proteolysis (5%)   
CLE650 GW849656 Carboxypeptidase N polypeptide 1 - 1.84 0.0052 
CE1303 GO376762 F-box and leucine-rich repeat protein 18 - 1.21 0.0082 
     
Protein folding (5%)   
CSMI546 GO388637 Peptidyl-prolyl cis-trans isomerase FKBP5 - 1.24 0.0022 
CPY173 GO387434 Heat shock cognate 70 kDa protein - 1.24 0.0081 
     
Regulation of transcription (5%)   
NM814 N/A Transcription factor IIIA - 1.49 0.0131 
NM115 N/A Protein strawberry notch homolog 1 1.23 0.0172 
     
Translation (25%)   
CE2965 GO378001 40S ribosomal protein S15a - 1.23 0.0006 
CE2958 GW843393 60S ribosomal protein L13 - 1.33 0.0011 
CE2753 GW843313 Elongation factor 1-alpha - 1.22 0.0038 
CE102 GO376549 60S ribosomal protein L27a - 1.26 0.0055 
CE916 GO378560 60S ribosomal protein L27 - 1.22 0.0068 
35 
 
CE1965 GW843877 60S ribosomal protein L38 - 1.23 0.0077 
CHO1803 GO381721 Elongation factor 1-beta  - 1.20 0.0098 
CE2064 GW842964 60S ribosomal protein L6 - 1.22 0.0111 
CHY916 GO383943 Eukaryotic translation initiation factor 3 subunit F  - 1.27 0.0115 
CLE430 GO384373 Polyadenylate-binding protein 1 - 1.24 0.0137 
CSMI161 GO388318 60S ribosomal protein L35 - 1.22 0.0154 
CE2959 GO377996 40S ribosomal protein S17 - 1.21 0.0166 
     
Cell proliferation, differentiation and apoptosis (20%)   
CTE684 GW861483 Tumor protein p63 regulated 1  1.22 0.0007 
CTE495 GO391915 40S ribosomal protein SA 2.03 0.0011 
NM303 N/A Tumor suppressor candidate 2 - 1.22 0.0017 
NM253 N/A Proline-rich protein BCA3-like  - 1.37 0.0032 
CHJ1269 GO380651 Translationally-controlled tumor protein homolog  - 1.26 0.0040 
NM449 N/A origin recognition complex, subunit 2-like  2.32 0.0096 
CHJ1272 GO380654 Translationally-controlled tumor protein homolog  - 1.23 0.0104 
CHO1630 GW846809 Caspase 3 1.21 0.0106 
CTA632 GO390541 Translationally-controlled tumor protein homolog  - 1.22 0.0107 
CTA484 GO390436 Translationally-controlled tumor protein homolog  - 1.23 0.0108 
CPY269 GO387613 Retinoic acid receptor responder protein 3 2.38 0.0110 
CSMI714 GW860190 Translationally-controlled tumor protein homolog - 1.24 0.0111 
COV1041 GW855020 Voltage-dependent anion-selective channel protein 1 1.22 0.0135 
CE1707 GO377048 Translationally-controlled tumor protein homolog  - 1.27 0.0161 
CTE1915 GO391572 Caspase-3 subunit p12 1.38 0.0176 
     
Structural molecule (9%)   
CTE1047 GO390866 Tektin-4 1.26 0.0067 
CE2716 GO377798 Tropomyosin alpha-1 chain 1.53 0.0110 
CE2051 GW842958 Cadherin 3, type 1 - 1.20 0.0120 
COV757 GW855647 Claudin 4 - 1.33 0.0124 
     
Immune response (9%)   
CPY1238 GO387126 Viperin 1.37 0.0159 
CTE1043 GO390863 Barrier-to-autointegration factor 1.21 0.0159 
CSMI679 GO388738 Interferon-induced protein 44 1.60 0.0166 
CHO1910 GW846481 High affinity immunoglobulin epsilon receptor 
subunit gamma 
- 1.38 0.0177 
     
Miscellaneous or unknown function (14%)   
CE2960 GW843396 Autophagy-related protein 16-1 - 1.22 0.0052 
CTE324 GO391798 Endoribonuclease 1.65 0.0124 
CLE567 GO384459 Processed zona pellucida sperm-binding protein 3 - 1.37 0.0129 
NM762 N/A Omega-amidase NIT2-B 1.61 0.0140 
CHO673 GO382599 Hemoglobin beta 1 chain  - 1.68 0.0153 
CTE829 GW861558 Tetraspanin-14  1.21 0.0175 
 1000 
 1001 
 1002 
 1003 
 1004 
1005 
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 1005 
Table 9  1006 
GO analysis results showing significant enrichment, at an adjusted p-value of 1.825E-4, of 1007 
features for the molecular function category GO:0003779; actin binding (14.9% count in 1008 
selection; 1.8% count in total).  1009 
Probe No. Accession 
No. 
SwissProt Annotation Fold change 
(C66/C0) 
CE1462 GW842770 Myosin heavy chain 1.38 
CE2112 GO377351 Tropomyosin 1 (alpha)  1.42 
CE2636 GW843270 Actin, alpha cardiac muscle 1 - 1.21 
CE2716 GO377798 Tropomyosin 1 (alpha)  1.53 
CE457 GO378247 Tropomyosin 1 (alpha)  1.43 
CE551 GO378302 Tropomyosin 1 (alpha)  1.46 
CHJ685 GO381113 Actin, alpha cardiac muscle 1 - 1.26 
CHO2151 GO382012 Actin, alpha cardiac muscle 1 - 1.21 
CHY703 GO383785 Actin, alpha cardiac muscle 1 - 1.23 
COV1757 GW855413 Cofilin 1 (non-muscle)  1.82 
COV702 GW855592 Ectodermal-neural cortex (with BTB-like domain)  1.80 
CSMI989 GW859865 Actin, alpha cardiac muscle 1 - 1.21 
CTA516 GO390453 Tropomyosin 1 (alpha)  1.41 
CTE369 GO391832 Transgelin  1.57 
CTE807 GO392129 Transgelin  1.60 
 1010 
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 1011 
Table 10  1012 
Validation, by RT-qPCR, of selected genes found to be significantly different when expressed in 1013 
the microarray analysis. Indicated is the fold change (FC) between expression levels in diets C66 1014 
and C0 and p-value (assessed by REST2008) of the RT-qPCR analysis. Asterisks indicate fold 1015 
changes, assessed by RT-qPCR, that are statistically significant.  1016 
Genes Microarray  RT-qPCR 
 FC (C66/C0)  FC (C66/C0)  p-value 
Elongation factor 1-alpha (elf1a) -1.22  1.18 0.095 
60S ribosomal protein L13 (rpl13) -1.33  -1.00 0.983 
Eukaryotic translation initiation factor 3 subunit F (etf3f) -1.27  -1.00 0.985 
Tumor protein p63 regulated 1-Like (tprg1l) 1.22  1.14 0.256 
Retinoic acid receptor responder protein 3 (rarres3) 2.38  *7.81 0.014 
40S ribosomal protein SA (rpsa) 2.03  1.03 0.658 
Translationally-controlled tumor protein homolog (tctp) 1.26  -1.23 0.136 
Caspase 3 (casp3) 1.21  *1.89 0.000 
Tropomyosin alpha-1 chain (tpm) 1.53  *1.55 0.036 
Tektin-4 (tekt4) 1.26  -1.33 0.341 
Cadherin 3 type 1 (cdh3) -1.20  1.01 0.921 
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